This article looks at the Cell and gene therapies (CGT) landscape, the challenges biopharma companies face in running clinical trials and tips on how to surmount those obstacles.

Related Information

Whitepaper

Mainstreaming Cell & Gene Therapies

Webpage

Cell and Gene Therapies

Blog

Clinical development challenges faced by advanced therapies for rare disease

Media Article

Cell and gene therapy specific market authorisation guidances